Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Role of Maintenance Therapy in Metastatic Colorectal Cancer

The Role of Maintenance Therapy in Metastatic Colorectal Cancer Letters Editorial Note: This letter was shown to the corresponding author of the Zi-Xian Wang, MD original article, who declined to reply on behalf of the authors. Fei Liang, MD 1. Connor MJ, Winkler M, Ahmed HU. Survival in oligometastatic prostate Rui-Hua Xu, MD cancer—a new dawn or the Will Rogers phenomenon? JAMA Oncol. 2020;6(2): 185-186. doi:10.1001/jamaoncol.2019.4724 Author Affiliations: Department of Medical Oncology, State Key Laboratory of 2. Evangelista L, Zattoni F, Guttilla A, et al. Choline PET or PET/CT and Oncology in South China, Collaborative Innovation Center for Cancer Medicine, biochemical relapse of prostate cancer: a systematic review and meta-analysis. Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, China Clin Nucl Med. 2013;38(5):305-314. doi:10.1097/RLU.0b013e3182867f3c (Wang, Xu); Department of Biostatistics, Zhongshan Hospital, Fudan University, Shanghai, China (Liang). 3. Perera M, Papa N, Roberts M, et al. Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated Corresponding Author: Rui-Hua Xu, MD, Department of Medical Oncology, diagnostic utility, sensitivity, specificity, and distribution of prostate-specific State Key Laboratory of Oncology in South China, Collaborative Innovation membrane antigen-avid lesions: a systematic review and meta-analysis Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun [published online February 14, 2019]. Eur http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

The Role of Maintenance Therapy in Metastatic Colorectal Cancer

JAMA Oncology , Volume 6 (6) – Jun 16, 2020

Loading next page...
 
/lp/american-medical-association/the-role-of-maintenance-therapy-in-metastatic-colorectal-cancer-tYvfs2MTZ7

References (5)

Publisher
American Medical Association
Copyright
Copyright 2020 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2020.0580
Publisher site
See Article on Publisher Site

Abstract

Letters Editorial Note: This letter was shown to the corresponding author of the Zi-Xian Wang, MD original article, who declined to reply on behalf of the authors. Fei Liang, MD 1. Connor MJ, Winkler M, Ahmed HU. Survival in oligometastatic prostate Rui-Hua Xu, MD cancer—a new dawn or the Will Rogers phenomenon? JAMA Oncol. 2020;6(2): 185-186. doi:10.1001/jamaoncol.2019.4724 Author Affiliations: Department of Medical Oncology, State Key Laboratory of 2. Evangelista L, Zattoni F, Guttilla A, et al. Choline PET or PET/CT and Oncology in South China, Collaborative Innovation Center for Cancer Medicine, biochemical relapse of prostate cancer: a systematic review and meta-analysis. Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, China Clin Nucl Med. 2013;38(5):305-314. doi:10.1097/RLU.0b013e3182867f3c (Wang, Xu); Department of Biostatistics, Zhongshan Hospital, Fudan University, Shanghai, China (Liang). 3. Perera M, Papa N, Roberts M, et al. Gallium-68 prostate-specific membrane antigen positron emission tomography in advanced prostate cancer—updated Corresponding Author: Rui-Hua Xu, MD, Department of Medical Oncology, diagnostic utility, sensitivity, specificity, and distribution of prostate-specific State Key Laboratory of Oncology in South China, Collaborative Innovation membrane antigen-avid lesions: a systematic review and meta-analysis Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Sun [published online February 14, 2019]. Eur

Journal

JAMA OncologyAmerican Medical Association

Published: Jun 16, 2020

There are no references for this article.